大型抑郁症的SuPAR:与26周抗抑郁药反应和10年抑郁症结果的关联
T H Haupt1,2, B Elfving3,4, J Eugen-Olsen1
1Department of Clinical Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Brain, behavior, & immunity - health
|September 21, 2023
概括
慢性炎症的升高,由可溶性泌尿酸酶等离子激素激活剂受体 (suPAR) 水平表明,与主要抑郁症 (MDD) 中更好的抗抑郁药 (AD) 治疗反应有关. 降低suPAR水平与症状改善相关.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
背景情况:
- 慢性炎症与抑郁症有关,并影响抗抑郁药 (AD) 治疗结果.
- 溶性泌尿酸酶等离子体激活受体 (suPAR) 作为慢性炎症的新生物标志物.
研究的目的:
- 调查suPAR水平,抑郁症严重程度和AD治疗反应之间的关联.
- 探索suPAR和长期精神病医院住院风险之间的关系.
主要方法:
- 一项为期26周的临床试验,涉及90名患有严重抑郁症 (MDD) 的患者,接受了埃斯基塔洛普拉姆或诺特利普提林治疗.
- 在基线和随访点 (8,12,26周) 测量了血清suPAR水平.
- 统计分析包括治疗反应的混合效应模型和住院风险的考克斯回归模型.
主要成果:
- 较高的基线suPAR水平与神经植物性抑郁症状的更严重程度有关.
- 响应阿尔茨海默病治疗的患者在基线上具有显著更高的suPAR水平.
- 在治疗期间,suPAR水平的降低与症状改善相关,特别是神经植物性症状.
结论:
- 根据suPAR的指标,慢性炎症的升高可能预示着对抗抑郁药物治疗的更好的反应.
- suPAR水平及其在治疗期间的变化为MDD的治疗反应机制提供了洞察力.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
G-protein Coupled Receptors
120.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.1K
Depression: Overview
271
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
271
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Antidepressant Drugs: Overview
547
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
547
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
428
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
428


